References
- Tosato G, Magrath I, Koski I, Dooley N, Blaese M. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med 1979; 301: 1133–1137
- Wang F, Blaese R M, Zoon K C, Tosato G. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis. J Clin Invest 1987; 79: 7–14
- Carter R L. Infectious mononucleosis: model for self-limiting lymphoproliferation. Lancet 1975; i: 846–849
- Tosato G, Straus S, Henle W, Pike S E, Blaese R M. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 1985; 134: 3082–3088
- Purtilo D T, Sakamoto K. Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression. Human Pathol 1981; 12: 677–679
- Peters H J. Heterophile reactive antigen in infectious mononucleosis. Science 1967; 157: 1200–1202
- Lukes R J, Cox F H. Clinical and morphologic findings in 30 fatal cases of infectious mononucleosis. Am J Pathol 1958; 34: 586
- Arm J P, Rainford D J, Turk E P. Acute renal failure and infectious mononucleosis. J Infection 1984; 9: 293–297
- Kopolovic J, Pinkus G, Rosen S. Interstitial nephritis in infectious mononucleosis. Am J Kidney Dis 1988; 12: 76–77
- Platt J L, Sibley R K, Michael A F. Interstitial nephritis associated with cytomegalovirus infection. Kidney Int 1985; 28: 550–552
- Straus S E, Tosato G, Armstrong G, Lawley T, Preble O T, Henle W, Davey R, Pearson G, Epstein J, Brus I, Blaese R M. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985; 102: 7–16
- López-Navidad A, Domingo P, Cadafalch J, Farrerons J, Allende L, Bordes R. Acute appendicitis complicating infectious mononucleosis. Case report and review. Rev Infect Dis 1990; 12: 297–302
- Lowery T A, Rutsky E A, Hartley M W, Andreoli T E. Renal failure in infectious mononucleosis. South Med J 1976; 69: 1212–1215
- Bennett W M, Barry J M, Houghton D C. Chronic tubulointer-stitial nephritis from infectious mononucleosis. West J Med 1980; 133: 248–249
- Tobi M, Morag A, Ravid Z, Chowers I, Feldman-Weiss V, Michaeli Y, Ben-Chetrit E, Shalit M, Knobler H. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infections. Lancet 1982; i: 61–64
- Andersson J, Britton S, Ernberg I, Andersson U, Henle W, Sköldenberg B, Tisell A. Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study. J Infect Dis 1986; 153: 283–290
- Hanto D W, Frizzera G, Gail-Pezalska K J, Balfour H H, Jr., Simmons R L, Najarian J S. Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant Proc 1985; 17: 89–92
- Schooley R T, Carey R W, Miller G, Henle W, Eastman R, Mark E J, Kenyon K, Wheeler E O, Rubin R H. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med 1986; 104: 636–643
- Straus S E, Dale J K, Tobi M, Lawley T, Preble O, Blaese R M, Hallahan C, Henle W. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med 1988; 319: 1692–1698
- Jones J F. Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother 1983; 12: 113–121